Literature DB >> 27581683

Effects of Alpha-Synuclein on Primary Spinal Cord Neurons Associated with Apoptosis and CNTF Expression.

Guo-Ying Feng1, Jia Liu2, You-Cui Wang3, Zhen-Yu Wang4, Yue Hu3, Qing-Jie Xia3, Yang Xu3, Fei-Fei Shang3, Mei-Rong Chen2, Fang Wang5, Xue Zhou6, Ting-Hua Wang7,8,9,10.   

Abstract

Spinal cord injury (SCI) often causes neurological deficits with poor recovery; the treatment, however, is far from satisfaction, and the mechanisms remain unclear. Using immunohistochemistry and western blotting analysis, we found α-synuclein (SNCA) was significantly up-regulated in the spinal caudal segment of rats subjected to spinal cord transection at 3 days post-operation. Moreover, the role of SNCA on neuronal growth and apoptosis in vitro was determined by using overexpressing and interfering SNCA recombined plasmid vectors, and the underlying mechanism was detected by QRT-PCR and western blotting. Spinal neurons transfected with SNCA-shRNA lentivirus gave rise to an optimal neuronal survival, while it results in cell apoptosis in SNCA-ORF group. In molecular level, SNCA silence induced the up-regulation of CNTF and down-regulation of Caspase7/9. Together, endogenous SNCA plays a crucial role in spinal neuronal survival, in which the underlying mechanism may be linked to the regulation both apoptotic genes (Caspase7/9) and CNTF. The present findings therefore provide novel insights into the role of SNCA in spinal cord and associated mechanism, which may provide novel cue for the treatment of SCI in future clinic trials.

Entities:  

Keywords:  Alpha-synuclein; Apoptotic gene; Ciliary neurotrophic factor; Primary spinal neurons; Spinal cord transection

Mesh:

Substances:

Year:  2016        PMID: 27581683     DOI: 10.1007/s10571-016-0420-x

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  47 in total

Review 1.  Locomotor performance and adaptation after partial or complete spinal cord lesions in the cat.

Authors:  S Rossignol; T Drew; E Brustein; W Jiang
Journal:  Prog Brain Res       Date:  1999       Impact factor: 2.453

2.  Dopaminergic neurons degenerate by apoptosis in Parkinson's disease.

Authors:  E C Hirsch; S Hunot; B Faucheux; Y Agid; Y Mizuno; H Mochizuki; W G Tatton; N Tatton; W C Olanow
Journal:  Mov Disord       Date:  1999-03       Impact factor: 10.338

3.  Selective hippocampal neuron loss in dementia with Lewy bodies.

Authors:  Antony J Harding; Bronwyn Lakay; Glenda M Halliday
Journal:  Ann Neurol       Date:  2002-01       Impact factor: 10.422

4.  Neuronal and glial apoptosis after traumatic spinal cord injury.

Authors:  X Z Liu; X M Xu; R Hu; C Du; S X Zhang; J W McDonald; H X Dong; Y J Wu; G S Fan; M F Jacquin; C Y Hsu; D W Choi
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

5.  The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.

Authors:  Marija Dulovic; Maja Jovanovic; Maria Xilouri; Leonidas Stefanis; Ljubica Harhaji-Trajkovic; Tamara Kravic-Stevovic; Verica Paunovic; Mustafa T Ardah; Omar M A El-Agnaf; Vladimir Kostic; Ivanka Markovic; Vladimir Trajkovic
Journal:  Neurobiol Dis       Date:  2013-11-20       Impact factor: 5.996

Review 6.  Modeling Lewy pathology propagation in Parkinson's disease.

Authors:  Kelvin C Luk; Virginia M-Y Lee
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

7.  Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice.

Authors:  Giorgio Vivacqua; Francesca Biagioni; Shun Yu; Arianna Casini; Domenico Bucci; Loredana D'Este; Francesco Fornai
Journal:  J Chem Neuroanat       Date:  2012-05-08       Impact factor: 3.052

8.  Distribution of α-synuclein in the spinal cord and dorsal root ganglia in an autopsy cohort of elderly persons.

Authors:  Hiroyuki Sumikura; Masaki Takao; Hiroyuki Hatsuta; Shinji Ito; Yuta Nakano; Akiko Uchino; Akane Nogami; Yuko Saito; Hideki Mochizuki; Shigeo Murayama
Journal:  Acta Neuropathol Commun       Date:  2015-09-15       Impact factor: 7.801

9.  DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease.

Authors:  M J Barallobre; C Perier; J Bové; A Laguna; J M Delabar; M Vila; M L Arbonés
Journal:  Cell Death Dis       Date:  2014-06-12       Impact factor: 8.469

10.  Soluble α-synuclein is a novel modulator of Alzheimer's disease pathophysiology.

Authors:  Megan E Larson; Mathew A Sherman; Susan Greimel; Michael Kuskowski; Julie A Schneider; David A Bennett; Sylvain E Lesné
Journal:  J Neurosci       Date:  2012-07-25       Impact factor: 6.167

View more
  5 in total

1.  In vitro neuroprotective effects of ciliary neurotrophic factor on dorsal root ganglion neurons with glutamate-induced neurotoxicity.

Authors:  Shu-Yun Wen; Ai-Min Li; Kuan-Qing Mi; Rui-Zheng Wang; Hao Li; Hua-Xiang Liu; Yi Xing
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

2.  Transcriptomic analysis of α-synuclein knockdown after T3 spinal cord injury in rats.

Authors:  Hong Zeng; Bao-Fu Yu; Nan Liu; Yan-Yan Yang; Hua-Yi Xing; Xiao-Xie Liu; Mou-Wang Zhou
Journal:  BMC Genomics       Date:  2019-11-14       Impact factor: 3.969

Review 3.  α-Synuclein in traumatic and vascular diseases of the central nervous system.

Authors:  Hong Zeng; Nan Liu; Xiao-Xie Liu; Yan-Yan Yang; Mou-Wang Zhou
Journal:  Aging (Albany NY)       Date:  2020-11-07       Impact factor: 5.682

Review 4.  Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?

Authors:  Bradley Roberts; Frances Theunissen; Francis L Mastaglia; P Anthony Akkari; Loren L Flynn
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

5.  Lentivirus-mediated downregulation of α-synuclein reduces neuroinflammation and promotes functional recovery in rats with spinal cord injury.

Authors:  Hong Zeng; Nan Liu; Yan-Yan Yang; Hua-Yi Xing; Xiao-Xie Liu; Fang Li; Gao-Yan La; Meng-Jie Huang; Mou-Wang Zhou
Journal:  J Neuroinflammation       Date:  2019-12-30       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.